Largest health care pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 52 health care pharmaceutical companies ranked by revenue, at TRY 4.76T, ahead of Eli Lilly (TRY 3.29T) and Merck & Co (TRY 3.28T). Figures as of 20 Nov 2026, 06:27 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- First
- Johnson & JohnsonTRY 4.76T
- Median
- TRY 161.8B
- Combined market value
- TRY 250.69T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
Health Care▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | TRY 4.76T | TRY 32.49T | TRY 13,495.75 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | TRY 3.29T | TRY 60.8T | TRY 68,257.77 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 3.28T | TRY 16.54T | TRY 6,709.48 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | TRY 3.16T | TRY 7.93T | TRY 1,391.30 | 1.85% down | 15% up | ||
| 5 | AbbVieABBV · Health Care | TRY 3.09T | TRY 25.32T | TRY 14,324.27 | 0.86% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | TRY 2.97T | TRY 13.74T | TRY 8,861.61 | 1.87% down | 1% up | ||
| 7 | NovartisNVS · Health Care | TRY 2.75T | TRY 14.43T | TRY 7,639.54 | 2.57% down | 25% up | ||
| 8 | SanofiSNY · Health Care | TRY 2.45T | TRY 5.59T | TRY 2,326.92 | 2.25% down | 4% down | ||
| 9 | Bristol-Myers SquibbBMY · Health Care | TRY 2.43T | TRY 6.02T | TRY 2,947.30 | 2.05% down | 30% up | ||
| 10 | Novo NordiskNVO · Health Care | TRY 2.32T | TRY 8.65T | TRY 1,963.69 | 1.42% down | 17% down | ||
| 11 | Abbott LaboratoriesABT · Health Care | TRY 2.24T | TRY 9.09T | TRY 5,247.45 | 0.58% down | 16% down | ||
| 12 | GSKGSK · Health Care | TRY 2.19T | TRY 4.84T | TRY 2,415.84 | 1.56% down | 5% up | ||
| 13 | Takeda PharmaceuticalTAK · Health Care | TRY 1.43T | TRY 3.46T | TRY 1,081.62 | 0.66% up | 51% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | TRY 871.9B | TRY 2.27T | TRY 1,947.02 | 8.74% down | 74% up | ||
| 15 | Regeneron PharmaceuticalsREGN · Health Care | TRY 724.6B | TRY 4.83T | TRY 46,646.58 | 2.35% down | 28% up | ||
| 16 | ViatrisVTRS · Health Care | TRY 722.4B | TRY 1.15T | TRY 1,004.33 | 1.97% down | 99% up | ||
| 17 | Vertex PharmaceuticalsVRTX · Health Care | TRY 606.3B | TRY 6.67T | TRY 26,303.43 | 2.94% down | 27% up | ||
| 18 | ZoetisZTS · Health Care | TRY 478.3B | TRY 1.66T | TRY 4,081.46 | 5.59% down | 26% down | ||
| 19 | GrifolsGRFS · Health Care | TRY 421.7B | TRY 281.9B | TRY 414.26 | 3.19% down | 0% up | ||
| 20 | BeOne MedicinesONC · Health Care | TRY 269.9B | TRY 2.31T | TRY 20,192.60 | 0.97% down | 16% up | ||
| 21 | Elanco Animal HealthELAN · Health Care | TRY 238.2B | TRY 663.8B | TRY 1,328.16 | 1.54% down | 26% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | TRY 215.6B | TRY 766.8B | TRY 11,945.31 | 4.57% down | 41% up | ||
| 23 | GenmabGMAB · Health Care | TRY 187.9B | TRY 1.6T | TRY 2,594.17 | 0.75% up | 70% up | ||
| 24 | Alnylam PharmaceuticalsALNY · Health Care | TRY 187.6B | TRY 1T | TRY 7,467.78 | 1.06% down | 66% down | ||
| 25 | Dr. Reddy's LaboratoriesRDY · Health Care | TRY 180.6B | TRY 624.6B | TRY 749.20 | 1.00% down | 8% up | ||
| 26 | BioMarin PharmaceuticalBMRN · Health Care | TRY 162.7B | TRY 601B | TRY 3,102.90 | 0.02% down | 17% up | ||
| 27 | United TherapeuticsUTHR · Health Care | TRY 160.8B | TRY 1.2T | TRY 28,245.40 | 3.16% down | 22% up | ||
| 28 | Amneal PharmaceuticalsAMRX · Health Care | TRY 152.5B | TRY 376.5B | TRY 1,080.61 | 2.24% down | 90% up | ||
| 29 | Royalty PharmaRPRX · Health Care | TRY 120.1B | TRY 1.97T | TRY 3,421.17 | 1.38% down | 79% up | ||
| 30 | PTC TherapeuticsPTCT · Health Care | TRY 87.4B | TRY 246.2B | TRY 2,946.54 | 3.16% down | 21% down | ||
| 31 | AlkermesALKS · Health Care | TRY 74.6B | TRY 392B | TRY 2,332.99 | 1.43% down | 66% up | ||
| 32 | Legend BiotechLEGN · Health Care | TRY 52B | TRY 157.8B | TRY 813.36 | 0.92% down | 41% down | ||
| 33 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 48.4B | TRY 465.6B | TRY 20,043.07 | 0.34% down | 27% down | ||
| 34 | Ionis PharmaceuticalsIONS · Health Care | TRY 47.7B | TRY 229B | TRY 1,375.14 | 0.62% down | 63% down | ||
| 35 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 41.9B | TRY 311.7B | TRY 2,205.17 | 1.25% up | 13% up | ||
| 36 | Ascendis PharmaASND · Health Care | TRY 40.4B | TRY 848.2B | TRY 12,930.95 | 5.32% down | 29% up | ||
| 37 | Corcept TherapeuticsCORT · Health Care | TRY 38.5B | TRY 359.3B | TRY 3,282.75 | 4.15% down | 10% down | ||
| 38 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | TRY 34.2B | TRY 371.3B | TRY 4,725.33 | 1.59% down | 129% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | TRY 32.3B | TRY 360.5B | TRY 6,854.47 | 1.25% up | 6% down | ||
| 40 | TG TherapeuticsTGTX · Health Care | TRY 31.1B | TRY 495.4B | TRY 3,277.70 | 1.88% down | 117% up | ||
| 41 | InsmedINSM · Health Care | TRY 30.6B | TRY 1.6T | TRY 7,298.03 | 20.58% up | 40% down | ||
| 42 | Mirum PharmaceuticalsMIRM · Health Care | TRY 26.3B | TRY 315B | TRY 4,825.11 | 3.27% up | 34% up | ||
| 43 | BridgeBio PharmaBBIO · Health Care | TRY 25.4B | TRY 769.4B | TRY 3,949.61 | 0.22% up | 21% up | ||
| 44 | Travere TherapeuticsTVTX · Health Care | TRY 24.8B | TRY 234.2B | TRY 2,440.09 | 3.86% down | 45% up | ||
| 45 | Ligand PharmaceuticalsLGND · Health Care | TRY 13.5B | TRY 290B | TRY 14,496.04 | 3.94% down | 50% up | ||
| 46 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 9.6B | TRY 409.1B | TRY 5,900.67 | 1.88% down | 18% up | ||
| 47 | CytokineticsCYTK · Health Care | TRY 4.4B | TRY 362.2B | TRY 2,599.73 | 0.27% up | 19% down | ||
| 48 | Protagonist TherapeuticsPTGX · Health Care | TRY 2.3B | TRY 408.9B | TRY 6,265.42 | 2.47% down | 51% up | ||
| 49 | Roivant SciencesROIV · Health Care | TRY 417.3M | TRY 1.43T | TRY 1,968.24 | 0.59% up | 91% up | ||
| 50 | Dianthus TherapeuticsDNTH · Health Care | TRY 102.9M | TRY 241.3B | TRY 4,285.56 | 1.01% up | 108% up | ||
| 51 | Spyre TherapeuticsSYRE · Health Care | TRY 0 | TRY 468.4B | TRY 4,932.21 | 3.77% down | 332% up | ||
| 52 | Praxis Precision MedicinesPRAX · Health Care | TRY 0 | TRY 439B | TRY 15,706.48 | 1.87% up | 86% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5194 TRY). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which health care pharmaceutical companies rank first by revenue?
Johnson & Johnson (TRY 4.76T), Eli Lilly (TRY 3.29T) and Merck & Co (TRY 3.28T) are the top three of the 52 health care pharmaceutical companies ranked by revenue as of 20 Nov 2026, 06:27 UTC.
How many health care pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these health care pharmaceutical companies worth together?
The 52 health care pharmaceutical companies ranked by revenue have a combined market value of TRY 250.69T as of 20 Nov 2026, 06:27 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care pharmaceutical companies by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?sector=health-care&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.